Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
| Index | S&P Developed Ex-Korea LargeMidCap ESG Enhanced Health Care |
| Investment focus | Equity, World, Health Care, Social/Environmental |
| Fund size | EUR 60 m |
| Total expense ratio | 0.18% p.a. |
| Replication | Physical (Full replication) |
| Legal structure | ETF |
| Strategy risk | Long-only |
| Sustainability | Yes |
| Fund currency | USD |
| Currency risk | Currency unhedged |
| Volatility 1 year (in EUR) | 16.36% |
| Inception/ Listing Date | 12 April 2023 |
| Distribution policy | Accumulating |
| Distribution frequency | - |
| Fund domicile | Ireland |
| Fund Provider | Invesco |
| Fund Structure | Open-ended Investment Company (OEIC) |
| UCITS compliance | Yes |
| Administrator | BNY Mellon Fund Services (Ireland) Designated Activity Company |
| Investment Advisor | Invesco Capital Management LLC |
| Custodian Bank | BNY Mellon Trust Company (Ireland) Limited |
| Revision Company | PricewaterhouseCoopers |
| Fiscal Year End | 31 December |
| Swiss representative | BNP Paribas, Paris, succursale de Zurich |
| Swiss paying agent | BNP Paribas, Paris, succursale de Zurich |
| Germany | Unknown |
| Switzerland | ESTV Reporting |
| Austria | Tax Reporting Fund |
| UK | UK Reporting |
| Indextype | Total return index |
| Swap counterparty | - |
| Collateral manager | |
| Securities lending | Yes |
| Securities lending counterparty |
| AbbVie, Inc. | 12.62% |
| Eli Lilly & Co. | 11.34% |
| AstraZeneca PLC | 5.63% |
| Merck & Co., Inc. | 4.45% |
| Roche Holding AG | 4.27% |
| Abbott Laboratories | 4.26% |
| UnitedHealth Group | 3.87% |
| Thermo Fisher Scientific | 3.76% |
| Gilead Sciences, Inc. | 3.71% |
| Novartis AG | 3.30% |
| United States | 69.24% |
| Switzerland | 8.84% |
| United Kingdom | 6.25% |
| Japan | 4.05% |
| Other | 11.62% |
| Health Care | 97.84% |
| Consumer Discretionary | 1.68% |
| Other | 0.48% |
| YTD | +1.64% |
| 1 month | +5.29% |
| 3 months | +10.74% |
| 6 months | +13.44% |
| 1 year | -1.94% |
| 3 years | - |
| 5 years | - |
| Since inception (MAX) | +12.75% |
| 2024 | +8.30% |
| 2023 | - |
| 2022 | - |
| 2021 | - |
| Volatility 1 year | 16.36% |
| Volatility 3 years | - |
| Volatility 5 years | - |
| Return per risk 1 year | -0.12 |
| Return per risk 3 years | - |
| Return per risk 5 years | - |
| Maximum drawdown 1 year | -19.93% |
| Maximum drawdown 3 years | - |
| Maximum drawdown 5 years | - |
| Maximum drawdown since inception | -21.52% |
| Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
|---|---|---|---|---|---|
| gettex | EUR | WH2E | - - | - - | - |
| Borsa Italiana | EUR | WDHE | WDHE IM WHCEINE | WDHE.MI I2PZINAV.DE | Societe Generale |
| London Stock Exchange | GBX | WHCG | WHCG LN WHCEINS | WHCG.L I2P0INAV.DE | Societe Generale |
| London Stock Exchange | USD | WHCE | WHCE LN WHCEIN | WHCE.L I2P1INAV.DE | Societe Generale |
| SIX Swiss Exchange | USD | WHCE | WHCE SW WHCEIN | WHCE.S I2P1INAV.DE | Societe Generale |
| XETRA | EUR | WH2E | WH2E GY WHCEINE | WH2E.DE I2PZINAV.DE | Societe Generale |
| Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
|---|---|---|---|---|
| iShares MSCI World Health Care Sector Advanced UCITS ETF USD (Dist) | 438 | 0.18% p.a. | Distributing | Full replication |